Finally, in area 3 we propose to perform detailed studies to charaderize the effeds of genetic variation on risk for lung cancer, allowing for effects from tobacco smoke and a limited set of additional environmental exposures that have been collected as a part of ILCCO. We will also explore the effects of genetic variation on smoking phenotypes. Area 3 analyses will allow a careful assessment of the joint effects of smoking and genetic exposures for a range of populations having different smoking behaviors, genetic backgrounds and effects from potential confounding fadors such as diet that have been measured in many cases, but with imprecision. In addition, we will be evaluating existing procedures for characterizing the risk for lung cancer according to age, sex, smoking behavior and demographic and medical history factors. We will also extend these models to include the results from the proposed genetic studies that we are conduding. The final product will be the development of a clearer view of lung carcinogenesis as well as better tools for identifying individuals at high risk to develop lung cancer. Identifying such people is an important goal, since there remain no approved screening mortalities for lung cancer in asymptomatic individuals because of a low positive predidive value of such approaches in the general population, and concern about the potential risks and costs associated with screening.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dartmouth College
United States
Zip Code
Lindström, Sara; Finucane, Hilary; Bulik-Sullivan, Brendan et al. (2017) Quantifying the Genetic Correlation between Multiple Cancer Types. Cancer Epidemiol Biomarkers Prev 26:1427-1435
Gorlova, Olga Y; Demidenko, Eugene I; Amos, Christopher I et al. (2017) Downstream targets of GWAS-detected genes for breast, lung, and prostate and colon cancer converge to G1/S transition pathway. Hum Mol Genet 26:1465-1471
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672
McKay, James D; Hung, Rayjean J; Han, Younghun et al. (2017) Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet 49:1126-1132
Lohavanichbutr, Pawadee; Sakoda, Lori C; Amos, Christopher I et al. (2017) Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clin Cancer Res 23:7550-7557
Byun, Jinyoung; Han, Younghun; Gorlov, Ivan P et al. (2017) Ancestry inference using principal component analysis and spatial analysis: a distance-based analysis to account for population substructure. BMC Genomics 18:789
Amos, Christopher I; Dennis, Joe; Wang, Zhaoming et al. (2017) The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev 26:126-135
Seow, Wei Jie; Matsuo, Keitaro; Hsiung, Chao Agnes et al. (2017) Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Hum Mol Genet 26:454-465
Feng, Yen-Chen Anne; Cho, Kelly; Lindstrom, Sara et al. (2017) Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics. Hum Genet 136:1341-1351

Showing the most recent 10 out of 129 publications